Answers are grounded in this paper and cite their sources.
Examines chebulagic acid's effects on T cell activation and cytokine production, suggesting potential therapeutic applications.
T cell activation and cytokine production are key components of the adaptive immune response, and their dysregulation is linked to various autoimmune and inflammatory disorders.Chebulagic acid, a tannin polyphenol from Terminalia bellirica (Gaertn.)Roxb., has shown promising immunomodulatory properties.In this study, we examined the effects of chebulagic acid on T cell activation markers (IL-2 receptor CD25 and HLA-DR) and secreted cytokines (IL-2, IL-6, IL-10, IL-12, TNF, IFN, and GM-CSF) in human peripheral blood mononuclear cells (PBMCs).Molecular docking showed chebulagic acid binds to CD25 (PDB: 7F9W) and HLA-DR (PDB: 7YX9) with affinities of -7.5 and -9.1 kcal/mol, respectively.Experimentally, chebulagic acid demonstrated inhibitory effect on both activation markers and cytokine production.These results suggest chebulagic acid can effectively modulate T cell responses, supporting further research into its mechanisms and potential therapeutic use in autoimmune and inflammatory diseases.
No takes yet. Share an insight, caveat, or question.
Nerlekar et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: